机译:ISHLT DCD肺移植登记处的5年结果证实了循环死亡捐赠者捐赠的优秀受体生存
Univ Hosp Leuven Leuven Belgium;
Univ Toronto Toronto ON Canada;
Alfred Hosp Melbourne Vic Australia;
UNOS Richmond VA USA;
Alfred Hosp Melbourne Vic Australia;
Univ Med Ctr Groningen Groningen Netherlands;
Harefield Hosp London England;
St Vincents Hosp Sydney NSW Australia;
Freeman Rd Hosp Newcastle Upon Tyne Tyne &
Wear England;
Columbia Univ Presbyterian Hosp New York NY USA;
Royal Papworth Hosp Cambridge England;
Cleveland Clin Cleveland OH 44106 USA;
Univ Minnesota Minneapolis MN USA;
Wythenshawe Hosp Manchester Lancs England;
Prince Charles Hosp Brisbane Qld Australia;
Univ Hosp Zurich Zurich Switzerland;
St Josephs Hosp Phoenix AZ USA;
Washington Univ St Louis MO USA;
Univ Hosp Birmingham Birmingham W Midlands England;
Loyola Univ Med Ctr Chicago IL USA;
Brigham &
Womens Hosp 75 Francis St Boston MA 02115 USA;
Baylor Univ Med Ctr Dallas TX USA;
Fiona Stanley Hosp Perth WA Australia;
Great Ormond St Children London England;
Freeman Rd Hosp Newcastle Upon Tyne Tyne &
Wear England;
Washington Univ St Louis MO USA;
Univ Utah Salt Lake City UT USA;
Univ Toronto Toronto ON Canada;
机译:ISHLT DCD肺移植登记处的5年结果证实了循环死亡捐赠者捐赠的优秀受体生存
机译:循环死亡(DCD)捐赠者的受控捐赠:重点是肺移植后的儿科供体和结果的利用
机译:循环确定死亡捐赠者(uDCDDs)作为移植肺源后的不受控制的捐赠
机译:具有或不具有阳性C4D染色的供体特异性抗体与肺移植受者的AMR和/或BOS相关联
机译:浆细胞骨髓瘤和类浆细胞瘤样移植后淋巴组织增生性疾病:移植受体科学注册中的生存分析。
机译:循环确定死亡供体(uDCDDs)作为移植肺源后的不受控制的捐赠
机译:循环死亡(DCD)供体和儿科肺移植(PLTX)的受控捐赠:增强的机遇和出色的结果